Risk factors for retinopathy of prematurity development and progression in the Philippines.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tan Roland Joseph D, Milante Rachel R, Te Adriel Vincent R, Ereño Esther Carmen Arvella G, Gonzales Redentor Caesar G, Flores-Anotado Jewel Faith, Uy Christopher Sebastian J, Macalma Knedrick Kevin, Santos-Rayos Jennifer Joy Y, Mangahas Lorenz Jacob D, Cabrera Karen R, Agcaoili Lyka R, Ecija Clyde Joshua A, Laddaran Tamilyn Chelsea C, Corpus-Velasquez Kristine D, Jimenez Iv Jose Melvin, Ilagan Kyla S, Daguman Ian J, Martinez Xavier Daryl L, Manzano Almira A, Moreno Ron Joseph R, Evangelista Gabrielle S, Taclobao Kanja Drisa, Marcelo-Tan Marie Christine T, Castillo Christian Q, Ibañez Iv Manuel Benjamin B, Precia Maijann D, Tacata Patricia S, Carbonell Robert Kelvin, Dator Dominico Carlo S, Tiburan Jemeson M, Anzures Rachelle G, Marohom Niño Enrico D, Lumontod Lois Agnes E, Quitos Margarita E, Aclan Beltran Alexis A, Uy Angeline Therese Y, Barja Claire Baldovino, Gambalan Van Alvin, Ongkeko Jona May S, Villanoy Gabriel L
Аннотация
METHODS: A multiregional ambispective cohort study of premature infants (<37wk gestational age) referred for ROP screening across 20 hospitals in 12 Philippine regions between January 2024 and September 2025 was conducted. Demographic, neonatal, and maternal risk factors were analyzed. Outcomes were compared between National Capital Region (NCR) and non-NCR cohorts.
RESULTS: Of 2085 referred infants, 1900 premature infants were included. Mean gestational age was 32.34±2.31wk; mean birthweight was 1593±439 g. ROP developed in 483 infants (25%), of whom 177 (37%) progressed to TOSA ROP. Lower gestational age, lower birthweight, male gender, and packed red blood cell transfusion were significantly associated with ROP development, whereas sepsis and oxygen supplementation were not. Among TOSA ROP cases, 87% received treatment, most commonly anti-vasular endothelial growth factor (VEGF) injection (46%) or laser photocoagulation (24%). At the last follow-up, 34% of treated infants had not reached full regression or retinal maturity. ROP incidence was higher in NCR (32%) than in Region I and Cordillera Administrative Region (8%, P=0.001), Region III (13%, P=0.005), and Region XI (14%, P=0.001), but lower than Region VI (55%, P=0.001).
CONCLUSION: Lower gestational age and birthweight, male, and packed red blood cell transfusion are risk factors of ROP development. This study also provides the first multiregional multicenter data on ROP in the Philippines, demonstrating substantial incidence and progression beyond NCR.